Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.7 (
plasmin
)
9,023
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
As a means of defining functionally important regions of the L1 neuronal cell adhesion molecule, neurite outgrowth from cerebellar neurons was compared on monolayers of L1-negative B28 glioma cells, B28 cells transfected with wild-type human L1, and B28 cells transfected with variant forms of L1. Neurite outgrowth on L1-positive B28 cells is greatly enhanced over that seen on parental B28 cells. Neurite outgrowth on B28 cells expressing L1 variants that lack either the first or the fifth
fibronectin type III repeat
is comparable to that seen on monolayers expressing wild-type L1. In contrast, B28 cells expressing L1 without the third
fibronectin type III repeat
do not support neurite outgrowth above the background level seen on parental B28 cells. This suggests that the third
fibronectin type III repeat
plays a key role in the ability of L1 to promote neurite extension. This is consistent with reports that the third
fibronectin type III repeat
mediates L1 homomultimerization and integrin binding and that
plasmin
cleavage within this domain interferes with L1 function by abolishing these molecular interactions.
...
PMID:The third fibronectin type III repeat is required for L1 to serve as an optimal substratum for neurite extension. 1086 97